ProstateCancerUpdate.net
Home: PCU 5|2004: Faculty disclosures

FACULTY

H Jeoffrey Deeths, MD
  Associate Clinical Professor
of Urology, Creighton Medical
School, Omaha, NE
William T Fagan, Jr, MD
  Retired Associate Professor of
Surgery/Urology, University of
Vermont College of Medicine
Burlington, VT
Keith W Gallehugh, MD
  Retired Chief of Radiology
Overland Park Regional Medical
Center, Overland Park, KS;
Retired Clinical Professor of
Radiology, University of Kansas
School of Medicine, Kansas
City, KS
Paul H Lange, MD
  Nelson Professor in Urology
Chairman, Department of Urology
University of Washington School
of Medicine, Urological Surgeon
in Chief, University of Washington
Medical Center, Seattle, WA
Colleen A Lawton, MD
  Professor of Radiation Oncology
Medical College of Wisconsin
Milwaukee, WI
Spencer Long, MD
  Tarboro Clinic, Tarboro, NC
Gustav Magrinat, MD
  Hematologist/Oncologist
Regional Cancer Center Breast
Cancer Program, Greensboro, NC
Judd W Moul, MD
  Professor and Chief, Division of
Urologic Surgery, Duke University
Medical Center, Durham, NC
Richard —, MD
  A medical oncologist on the
faculty of a medical school in
New England
Alan Roberts, MD
  Associate Professor of Medicine,
Section of General Internal
Medicine, Medical College of
Georgia; Chairman of the Medical
Ethics Committee, Director, Ethics
Consultation Service, Medical
College of Georgia Health Inc;
Director, MiniMedical School,
Medical College of Georgia,
Augusta, GA
Paul F Schellhammer, MD
  Professor, Eastern Virginia
Medical School, Norfolk, VA
David Shimm, MD
  Vice President, Beckley Oncology
Associates; Medical Director
Radiation Oncology, Raleigh
Regional Cancer Center
Beckley, WV
Marc A Shuman, MD
  Professor of Medicine and
Urology, University of California
San Francisco; Leader, Prostate
Cancer Program, UCSF
Comprehensive Cancer Center;
Principal Investigator, UCSF
Prostate Cancer SPORE,
San Francisco, CA
Ray E Stutzman, MD
  Staff Urologist, Walter Reed Army
Medical Center, Washington, DC
   
Special thanks to
Dr Mary-Ellen Taplin for
assisting with this project.

This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantor.


Disclosure

Dr Deeths – No financial interests or affiliations to disclose
Dr Fagan – No financial interests or affiliations to disclose
Dr Gallehugh – No financial interests or affiliations to disclose
Dr Lange Grants/Research Support and Honorarium: Abbott Laboratories, GlaxoSmithKline
Dr Lawton – No financial interests or affiliations to disclose
Dr Long – No financial interests or affiliations to disclose
Dr Magrinat – No financial interests or affiliations to disclose
Dr MoulHonorarium: AstraZeneca Pharmaceuticals LP, Merck and Company Inc,
Sanofi-Aventis, TAP Pharmaceuticals Inc
Richard – No financial interests or affiliations to disclose
Dr Roberts – No financial interests or affiliations to disclose
Dr SchellhammerGrants/Research Support: AstraZeneca Pharmaceuticals LP, Dendreon, GTx Inc, GlaxoSmithKline, Integrated Therapeutics Group, Sanofi-Aventis Consultant: Dendreon, Sanofi-Aventis
Dr Shimm – No financial interests or affiliations to disclose
Dr ShumanConsultant: Chiron Corporation, Karo Bio, XOMA (US) LLC
Dr Stutzman – No financial interests or affiliations to disclose

PURPOSE OF THIS ISSUE OF PROSTATE CANCER UPDATE

The purpose of Issue 5 of Prostate Cancer Update is to support these global objectives by offering the perspectives of clinicians with prostate cancer on these issues.


UPCOMING EDUCATIONAL EVENTS

2005 American Society of Clinical Oncology
Prostate Cancer Symposium:
February 17-19, 2005
Hyatt Grand Cypress
One Grand Cypress Blvd
Orlando, FL
Event website: ww.asco.org/ac/1,1003,_12-
002665-00_18-0034689,00.asp

41st American Society of Clinical Oncology
Annual Meeting: May 13-17, 2005
Orange County Convention Center
Orlando, FL
Event website: www.asco.org/ac/1,1003,_12- 002092,00.asp

10th National Comprehensive
Cancer Network Annual Conference:
March 16-20, 2005
  2005 American Urological
Association Annual Meeting:
May 21- 26, 2005
  Westin Diplomat
3555 South Ocean Drive,
Hollywood, FL
Event website : www.nccn.org/professionals/
meetings/10thannual/default.asp
  San Antonio, TX
Event website: www.aua2005.org/am05/?CFID =1463668&CFTOKEN=29660692
Challenging Cases in Urology:
February 24-26, 2005
  2005 American Society for Therapeutic
Radiology and Oncology Annual Meeting:
October 16-20, 2005
  Fountainbleau Hilton Hotel
Miami, FL
Contact phone: (770)-751-7332
  Denver, CO
Event website: www.astro.org/annual_meeting/
       

 
   

Home

Editor’s Note:
Visiting professors

The initial reaction to the diagnosis of prostate cancer
Discussing treatment options for localized disease
Treatment side effects and complications
Case discussion: Maximal androgen blockade and radiation therapy for PSA relapse
Psychosocial issues in prostate cancer
Case discussion: PSA progression after intolerable side effects from chemical castration
Case discussion: Androgen deprivation for metastatic
Case discussion: Open versus laparoscopic prostatectomy
Case discussion: In search of a radiation oncologist
Watchful waiting for low-risk disease
Complementary medicine and supportive care
Select publications

CME Information

Faculty Disclosures

Editor’s Office

 
Terms of use and general disclaimer
© Research To Practice, 2004. All rights reserved.